Solid Bio’s former CEO launches new rare disease startup with €65M Series A

A new startup aiming to tackle rare diseases de-stealthed Wednesday morning with a CEO experienced in the space.

Alesta Therapeutics took the wraps off its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

A Crisis Curveball at the Cubs Game

Listen and subscribe/follow on Apple and Spotify so you don’t miss the next episode. And if you like what you hear, a five-star rating goes

July 22, 2023

Pint Pharma announces ORLADEYO approval in Mexico for HAE

The oral medication is intended for use in patients over the age of 12 years to prevent hereditary angioedema. Credit: LeviaUA/ Shutterstock.com. Pint Pharma has

May 14, 2024

Study highlights negative consequences of exclusionary discipline

Suspending or expelling a student is one of the most severe punishments a school can impose on a student – and it can have lifelong,

October 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.